1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow GB-0139: new trials by email Literature Review of GB-0139 trials Research Report on GB-0139
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) GB0139, Placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Completed | Galecto Biotech AB | 172 | 2019-02-19 | 2024-05-22 |
Idiopathic Pulmonary Fibrosis (1)
Australia (1) · Belgium (1) · Canada (1) · France (1) · Georgia (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · Poland (1) · Russia (1) · Spain (1) · Ukraine (1) · United Kingdom (1) · United States (1)
2018 (1)